0001225208-15-001415.txt : 20150115
0001225208-15-001415.hdr.sgml : 20150115
20150115155553
ACCESSION NUMBER: 0001225208-15-001415
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150115
FILED AS OF DATE: 20150115
DATE AS OF CHANGE: 20150115
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Merck & Co., Inc.
CENTRAL INDEX KEY: 0000310158
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 221918501
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2000 GALLOPING HILL ROAD
CITY: KENILWORTH
STATE: NJ
ZIP: 07033
BUSINESS PHONE: 908-740-4000
MAIL ADDRESS:
STREET 1: 2000 GALLOPING HILL ROAD
CITY: KENILWORTH
STATE: NJ
ZIP: 07033
FORMER COMPANY:
FORMER CONFORMED NAME: Merck & Co. Inc.
DATE OF NAME CHANGE: 20091103
FORMER COMPANY:
FORMER CONFORMED NAME: SCHERING PLOUGH CORP
DATE OF NAME CHANGE: 19920703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Schechter Adam H
CENTRAL INDEX KEY: 0001376841
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-06571
FILM NUMBER: 15529998
MAIL ADDRESS:
STREET 1: MERCK & CO INC, ONE MERCK DRIVE
STREET 2: P O BOX 100
CITY: WHITEHOUSE STATION
STATE: NJ
ZIP: 08889-0100
4
1
doc4.xml
X0306
4
2015-01-15
0000310158
Merck & Co., Inc.
MRK
0001376841
Schechter Adam H
2000 GALLOPING HILL ROAD
KENILWORTH
NJ
07033
1
EVP & Pres-Global Human Health
Common Stock
2015-01-15
4
M
0
50000.0000
44.1900
A
50000.0000
D
Common Stock
2015-01-15
4
M
0
19200.0000
35.0900
A
69200.0000
D
Common Stock
2015-01-15
4
M
0
5000.0000
34.4700
A
74200.0000
D
Common Stock
2015-01-15
4
S
0
74200.0000
62.4828
D
0.0000
D
Common Stock
70794.9747
I
By Trust
Stock Option (right to buy)
34.4700
2015-01-15
4
M
0
5000.0000
0.0000
D
2007-02-01
2016-01-31
Common Stock
5000.0000
0.0000
D
Stock Option (right to buy)
44.1900
2015-01-15
4
M
0
50000.0000
0.0000
D
2008-03-02
2017-03-01
Common Stock
50000.0000
0.0000
D
Stock Option (right to buy)
35.0900
2015-01-15
4
M
0
19200.0000
0.0000
D
2007-03-03
2016-03-02
Common Stock
19200.0000
0.0000
D
The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.1200 to $62.9800, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote.
Holdings include shares acquired in dividend reinvestment transactions.
The option became exercisable in equal installments on 2/1/2007, 2/1/2008 and 2/1/2009.
The option became exercisable in equal installments on 3/2/2008, 3/2/2009 and 3/2/2010.
The option became exercisable in equal installments on 3/3/2007, 3/3/2008 and 3/3/2009.
Katie Fedosz as Attorney-in-Fact for Adam H. Schechter
2015-01-15